share_log

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $14 Price Target

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $14 Price Target

HC Wainwright & Co.重申买入 ProPhase Labs,维持14美元的目标价
Benzinga ·  2023/06/02 06:35

HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $14 price target.

HC Wainwright&Co.分析师陈毅重申前期实验室(纳斯达克:PRPH)的买入,并维持14美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发